(CLOI) VanEck Trust - VanEck CLO - Ratings and Ratios
Loan, Securities, Senior, Debt, Structured
Description: CLOI VanEck Trust - VanEck CLO
The VanEck CLO ETF (CLOI) is an Ultrashort Bond ETF listed on the NYSE ARCA, providing investors with exposure to a diversified portfolio of Collateralized Loan Obligations (CLOs). CLOs are structured finance securities backed by a pool of loans, typically leveraged loans, which are often used by companies to finance various business activities.
The ETFs investment objective is to provide income and total return, primarily through investing in a diversified portfolio of CLOs. The performance of CLOI is closely tied to the overall health of the leveraged loan market, which is influenced by factors such as interest rates, credit spreads, and the overall economic environment. Key economic drivers for CLOI include the Federal Reserves monetary policy decisions, credit market conditions, and the default rates of the underlying loans.
To evaluate the performance of CLOI, key performance indicators (KPIs) such as yield, duration, and credit quality can be used. The yield on CLOI is expected to be influenced by the yield on the underlying CLOs, which in turn is driven by the creditworthiness of the borrowers and the overall market conditions. A higher yield typically indicates a higher perceived risk, while a lower yield indicates a lower perceived risk.
The AUM of $1.121 billion indicates a sizable investor base, which can contribute to liquidity and stability in the ETFs shares. The low beta of 0.100 suggests that CLOIs returns are relatively insensitive to broader market movements, making it a potentially useful diversifier in a portfolio. However, the ultrashort bond category is subject to interest rate risk, and changes in monetary policy can impact the ETFs performance.
CLOI ETF Overview
Market Cap in USD | 1,196m |
Category | Ultrashort Bond |
TER | 0.40% |
IPO / Inception | 2022-06-21 |
CLOI ETF Ratings
Growth Rating | 58.9% |
Fundamental | - |
Dividend Rating | 72.6% |
Return 12m vs S&P 500 | -10.1% |
Analyst Rating | - |
CLOI Dividends
Dividend Yield 12m | 5.57% |
Yield on Cost 5y | 6.91% |
Annual Growth 5y | 46.41% |
Payout Consistency | 100.0% |
Payout Ratio | % |
CLOI Growth Ratios
Growth Correlation 3m | 98.3% |
Growth Correlation 12m | 96.6% |
Growth Correlation 5y | 99.7% |
CAGR 5y | 7.68% |
CAGR/Max DD 3y | 0.00 |
CAGR/Mean DD 3y | 0.00 |
Sharpe Ratio 12m | 0.37 |
Alpha | -9.12 |
Beta | 0.664 |
Volatility | 1.64% |
Current Volume | 69.9k |
Average Volume 20d | 131.2k |
Stop Loss | 51.3 (-3.1%) |
Signal | 1.44 |
What is the price of CLOI shares?
Over the past week, the price has changed by +0.02%, over one month by +0.57%, over three months by +1.63% and over the past year by +6.28%.
Is VanEck Trust - VanEck CLO a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CLOI is around 53.76 USD . This means that CLOI is currently overvalued and has a potential downside of 1.53%.
Is CLOI a buy, sell or hold?
What are the forecasts/targets for the CLOI price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 59.9 | 13.2% |
Last update: 2025-09-15 04:33
CLOI Fundamental Data Overview
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 USD
Beta = 0.12
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 1.20b USD (1.20b + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 1.20b)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 1.20b / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default)
NOPAT = 0.0 (EBIT 0.0, no tax applied on loss)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(1.20b)/V(0.0) * Re(8.46%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(0.21)))
Discount Rate = 8.46% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for CLOI ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle